Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
NCV Stock Summary
Top 10 Correlated ETFs
NCV
In the News

NCV: The Preferred Shares Look More Attractive Than The Common
Virtus Convertible & Income Fund is a closed-end fund focused on domestic convertible securities and high-yield bonds. The fund has a 22% leverage ratio, mainly obtained through an outstanding series of preferred shares.

Weekly Closed-End Fund Roundup: March 12, 2023
Three out of 22 CEF sectors positive on price and 5 out of 22 sectors positive on NAV last week. Delaware/Abrdn mergers are closed.

CEF Weekly Review: More Of The Same On The Distribution Front
We review CEF market valuation and performance through the second week of March and highlight recent market action. CEFs mostly struggled, outside of the higher-quality sectors as two bank failures spooked markets.

NCV And NCZ: Discounts Narrow For Both, But One Looking More Appealing
NCV and NCZ have seen their discounts narrow from the wide discount we saw several months ago. NCZ presents a potentially better opportunity with a larger discount compared to NCV.

Weekly Closed-End Fund Roundup: Tortoise Tender Results, NCZ Resumes Distributions (November 6, 2022)
12 out of 23 CEF sectors positive on price and 6 out of 23 sectors positive on NAV last week. Tortoise offer tender results.

NCZ: Distribution Suspension And Resumption Creates Swap Opportunity With NCV
NCZ has suspended, and resumed, distributions. Both NCV and NCZ have deleveraged by redeeming their ARPS.

Weekly Closed-End Fund Roundup: Tortoise Tender Offers Expiring (October 23, 2022)
16 out of 23 CEF sectors positive on price and 12 out of 23 sectors positive on NAV last week. Watch for overvalued CEFs as market volatility rises.

Virtus Convertible & Income Fund: Better Valuation, But Still Cautious
Since the last time we touched on NCV, the fund's discount has widened meaningfully. Its sister fund NCZ has had to suspend its distribution a couple of times this year.

Weekly Closed-End Fund Roundup: BlackRock CEFs Repurchasing Shares (October 16, 2022)
0 out of 23 CEF sectors are positive on price and 0 out of 23 sectors are positive on NAV over the last week. BlackRock CEFs are repurchasing their shares.

Bargain Hunting Time: 3 Deeply Discounted Funds Yielding 12%+
This selloff has set up a very rare opportunity to bag 12%+ yields
NCV Financial details
NCV Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-01-31
Metric | History | 2018-02-28 | 2019-02-28 | 2020-02-29 | 2021-02-28 | 2023-01-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.62 | -0.07 | 0.71 | 1.8 | 0 | |
Net income per share | 0.61 | -0.08 | 0.69 | 1.79 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0.01 | 0 | 0 | 0 | |
Book value per share | 12.27 | 9.22 | 12.38 | 10.45 | 0 | |
Tangible book value per share | 12.27 | 9.22 | 12.38 | 10.45 | 0 | |
Share holders equity per share | 12.27 | 9.22 | 12.38 | 10.45 | 0 | |
Interest debt per share | 0 | 0.33 | 0.46 | 0.34 | 0 | |
Market cap | 529.56M | 559.19M | 331.55M | 506.87M | 0 | |
Enterprise value | 529.56M | 586.72M | 360.41M | 535.72M | 169.9M | |
P/E ratio | 11.39 | -76.09 | 7.37 | 3.26 | 0 | |
Price to sales ratio | 11.16 | -91.97 | 7.22 | 3.24 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0.56 | 0.68 | 0.41 | 0.56 | 0 | |
PTB ratio | 0.56 | 0.68 | 0.41 | 0.56 | 0 | |
EV to sales | 11.16 | -96.5 | 7.85 | 3.43 | -2.12 | |
Enterprise value over EBITDA | 11.39 | -91.23 | 8.02 | 3.44 | -2.09 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 1.4 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 1.4 | |
Earnings yield | 0.09 | -0.01 | 0.14 | 0.31 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.03 | 0.04 | 0.03 | 0.36 | |
Debt to assets | 0 | 0.03 | 0.03 | 0.03 | 0.26 | |
Net debt to EBITDA | 0 | -4.28 | 0.64 | 0.19 | -2.09 | |
Current ratio | 2.11 | 0.8 | 2.08 | 0.32 | 0.76 | |
Interest coverage | 0 | -7.01 | 56.35 | 554.52 | -35.99 | |
Income quality | 0 | 0 | 0 | 0 | -1.33 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | -0.57 | |
Sales general and administrative to revenue | 0.02 | -0.2 | 0.02 | 0.01 | -0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 12.96 | 4.12 | 13.88 | 20.53 | 0 | |
ROIC | 0.05 | -0.01 | 0.05 | 0.17 | -0.13 | |
Return on tangible assets | 0.05 | -0.01 | 0.05 | 0.16 | -0.12 | |
Graham Net | 0.06 | -0.47 | -0.47 | -0.55 | 0 | |
Working capital | 9.59M | -6.58M | 8.07M | -16.31M | -4.27M | |
Tangible asset value | 937.87M | 825.92M | 804.91M | 907.22M | 468.41M | |
Net current asset value | 9.17M | -35.81M | -26.37M | -45.64M | -175.04M | |
Invested capital | 0 | 0.03 | 0.04 | 0.03 | 0.36 | |
Average receivables | 16.01M | 21.27M | 19.94M | 11.58M | 0 | |
Average payables | 4.32M | 20.43M | 19.86M | 15.7M | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 140.14 | -1.46K | 123.79 | 17.73 | -59.83 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 2.6 | -0.25 | 2.95 | 20.59 | -6.1 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.05 | -0.01 | 0.06 | 0.17 | -0.17 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-01-31 for Q4
Metric | History | 2020-08-31 | 2021-02-28 | 2021-08-31 | 2022-07-31 | 2023-01-31 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 28.85M | 28.84M | 28.75M | -100K | 169.9M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.04 | 0.03 | 0.03 | 0 | 0.36 | |
Debt to assets | 0.03 | 0.03 | 0.03 | 0 | 0.26 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 1.75 | 0.32 | 1.39 | 1.22 | 0.76 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 3.94M | -16.31M | 2.73M | 1.78M | -4.27M | |
Tangible asset value | 813.7M | 907.22M | 900.54M | 713.02M | 468.41M | |
Net current asset value | -25.21M | -45.64M | -35.12M | 992K | -175.04M | |
Invested capital | 0.04 | 0.03 | 0.03 | 0 | 0.36 | |
Average receivables | 12.37M | 8.39M | 7.49M | 0 | 11.42M | |
Average payables | 6.37M | 14.57M | 15.48M | 0 | 12.77M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
NCV Frequently Asked Questions
What is Virtus AllianzGI Convertible & Income Fund stock symbol ?
Virtus AllianzGI Convertible & Income Fund is a US stock , located in New york of Ny and trading under the symbol NCV
What is Virtus AllianzGI Convertible & Income Fund stock quote today ?
Virtus AllianzGI Convertible & Income Fund stock price is $3.0679 today.
Is Virtus AllianzGI Convertible & Income Fund stock public?
Yes, Virtus AllianzGI Convertible & Income Fund is a publicly traded company.